SOMAXON PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4acc3d71-da8f-48b7-83de-625c79c0c3a1/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2011 | $-57.4M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-105189 |
| FY 2010 | $-39.0M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-105189 |
| FY 2009 | $-14.2M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-105189 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).